Início › Câncer de Bexiga › Califórnia › Los Angeles
Ensaios clínicos de Câncer de Bexiga em Los Angeles, CA
24 estudos para Câncer de Bexiga estão buscando participantes em locais em Los Angeles e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
RecrutandoFase 2
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RecrutandoFase 1
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
RecrutandoFase 2
- USC Norris Comprehensive Cancer Center ( Site 0123), Los Angeles
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
RecrutandoFase 2
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
- Cedars-Sinai Medical Center, Los Angeles
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
RecrutandoFase 1
- Ronald Reagan UCLA Medical Center, Los Angeles
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RecrutandoFase 2
- Keck Medicine of USC Koreatown, Los Angeles
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
RecrutandoFase 1/2
- START Los Angeles, LLC, Los Angeles
- Los Angeles Cancer Network - Century City, Los Angeles
- (IRB# 26-0433) Ronald Reagan UCLA Medical Center, Drug Information Center, Los Angeles
- e mais 1
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
RecrutandoFase 3
- TRIO-US (Translational Research in Oncology-US), Los Angeles
- UCLA Hematology/Oncology - Santa Monica, Los Angeles
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
RecrutandoFase 1
- USC/Norris Comprehensive Cancer Center, Los Angeles
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
RecrutandoFase 2/3
- Research Site, Los Angeles
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
RecrutandoFase 1
- University of California, Los Angeles (UCLA) - Division of Hematology-Oncology, Los Angeles
A Study of MGC026 in Participants With Advanced Solid Tumors
RecrutandoFase 1
- The Angeles Clinic and Research Institute, Los Angeles
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
RecrutandoFase 1/2
- USC/Norris Comprehensive Cancer Center, Los Angeles
- Tower Urology, Los Angeles
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
RecrutandoFase 2
- UCLA Downtown Los Angeles Primary & Specialty Care, Los Angeles
- Kaiser Permanente Los Angeles Medical Offices, Los Angeles
- Kaiser Permanente West Los Angeles Medical Center, Los Angeles
- e mais 6
A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
RecrutandoFase 1
- USC Norris Comprehensive Cancer Center, Los Angeles
Predicting BCG Response
RecrutandoEstudo observacional
- Cedars-Sinai Medical Center, Los Angeles
- UCLA, Los Angeles
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RecrutandoFase 1
- Ronald Reagan UCLA Medical Center, Los Angeles
- The Regents of the University of California, Los Angeles
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Recrutando
- Urology Group of Southern California, Los Angeles
- Comprehensive Urology, Los Angeles
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
RecrutandoFase 1
- USC - Norris Comprehensive Cancer Center, Los Angeles
A Novel Multiplex ELISA Assay for Surveilling Patients With History of Bladder Cancer
RecrutandoEstudo observacional
- Cedars-Sinai Medical Center, Los Angeles
A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer
RecrutandoEstudo observacional
- Cedars-Sinai Medical Center, Los Angeles
- UCLA Medical Center, Los Angeles
Blue Light Cystoscopy With Cysview® Registry
RecrutandoEstudo observacional
- USC/Norris Comprehensive Cancer Center, Los Angeles
- University of California Los Angeles, Los Angeles
Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy
Recrutando
- Cedars-Sinai Medical Center (CSMC), Los Angeles
- University of California Los Angeles, Los Angeles
Deceased Donor Bladder or Combined Kidney-bladder Transplantation: a Phase 0 First-in-human Study
Recrutando
- UCLA, Los Angeles
Ensaios de Câncer de Bexiga em outras cidades
- New York City, NY35 estudos
- Nashville, TN31 estudos
- Houston, TX31 estudos
- Dallas, TX27 estudos
- Washington, DC26 estudos
- Boston, MA26 estudos
- Baltimore, MD24 estudos
- St. Louis, MO22 estudos
- Seattle, WA21 estudos
- Edison, NJ21 estudos
- Philadelphia, PA21 estudos
- Chicago, IL21 estudos
Outros estudos em Los Angeles
- Câncer de Pulmão de Não Pequenas Células87 estudos
- Câncer (todos os tipos)74 estudos
- Câncer de Mama73 estudos
- Câncer de Próstata61 estudos
- Câncer Colorretal59 estudos
- Câncer Metastático57 estudos
- Câncer de Ovário50 estudos
- Câncer de Pulmão45 estudos
- Carcinoma de Células Escamosas de Cabeça e Pescoço42 estudos
- Câncer de Pâncreas35 estudos
- Câncer Endometrial34 estudos
- Melanoma34 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.